Literature DB >> 10080441

Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care.

J T Dell'Orfano1, H Patel, D L Wolbrette, J C Luck, G V Naccarelli.   

Abstract

Acute treatment of atrial fibrillation is costly although spontaneous conversion rates are high. We reviewed 114 patients admitted to our inpatient service via the emergency department with a principal diagnosis of atrial fibrillation and found the spontaneous conversion rate was 50% in 48 hours, the average length of stay was 3.9 +/- 5.2 days, and the average cost was $6,692 +/- $4,928.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10080441     DOI： 10.1016/s0002-9149(98)00993-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 2.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 3.  A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation.

Authors:  Gerald V Naccarelli; Deborah L Wolbrette; Luna Bhatta; Mazhar Khan; John Hynes; Soraya Samii; Jerry Luck
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

4.  Incident atrial fibrillation in the emergency department in Ontario: a population-based retrospective cohort study of follow-up care.

Authors:  Clare L Atzema; Bing Yu; Noah Ivers; Paula Rochon; Douglas S Lee; Michael J Schull; Peter C Austin
Journal:  CMAJ Open       Date:  2015-04-02

Review 5.  [Atrial fibrillation].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

Review 6.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Left atrial enlargement as a predictor of recurrences in lone paroxysmal atrial fibrillation.

Authors:  Valerio Zacà; Maurizio Galderisi; Sergio Mondillo; Marta Focardi; Piercarlo Ballo; Francesco Guerrini
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

8.  Is delayed cardioversion the better approach in recent-onset atrial fibrillation? Yes.

Authors:  Giovanni Luca Botto; Giovanni Tortora
Journal:  Intern Emerg Med       Date:  2019-12-13       Impact factor: 3.397

9.  Clinical outcomes of atrial fibrillation with hyperthyroidism.

Authors:  Muhammad Zubair Khan; Ashwani Gupta; Jordesha Hodge; Kirtenkumar Patel; Krunalkumar Patel; Muhammad Samsoor Zarak; Sona Franklin; Harsh Patel; Shruti Jesani; Sejal Savani; Vraj Shah; Vincent M Figueredo; Arvind R Cavale; Steven Kutalek
Journal:  J Arrhythm       Date:  2021-07-07

10.  Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study.

Authors:  Hesham S Taha; Ghada Youssef; Ramy M Omar; Ahmed M Kamal El Din; Ahmed A Shams El Din; Marwa S Meshaal
Journal:  Indian Heart J       Date:  2022-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.